Low LDL-C: Is It all Good News?

被引：0
|
作者：
Hartz, Jacob [1 ]
机构：
[1] Boston Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA
来源：
CURRENT ATHEROSCLEROSIS REPORTS | 2024年 / 26卷 / 12期
基金：
美国国家卫生研究院;
关键词：
Hypobetalipoproteinemia; Lipid-lowering therapy; Atherosclerotic cardiovascular disease; Adverse effects; LOW-DENSITY-LIPOPROTEIN; FAMILIAL COMBINED HYPOLIPIDEMIA; VERY-LOW LEVELS; STATIN THERAPY; HEMORRHAGIC STROKE; APO-B; TOO LOW; CHOLESTEROL; RISK; SAFETY;
D O I：
10.1007/s11883-024-01238-y
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
Purpose of reviewThis review presents the risks and benefits of very low LDL cholesterol and the safety of using lipid-lowering therapy to achieve these levels.Recent findingsA growing body of literature suggests that lower LDL cholesterol levels are associated with a reduced risk of cardiovascular disease. Further, achieving these levels with pharmaceuticals is remarkably safe. Although statins may slightly increase the risk of diabetes mellitus and hemorrhagic stroke, the benefits outweigh the risks.SummaryWhile recommendations from professional societies are increasingly aggressive, additional risk reduction could be achieved by setting more even ambitious LDL cholesterol goals.
引用
收藏
页码：673 / 681
页数：9
相关论文
共 50 条
  • [1] Is very low LDL-C harmful?
    Faselis, Charles
    Imprialos, Konstantinos
    Grassos, Haris
    Pittaras, Andreas
    Kallistratos, Manolis
    Manolis, Athanasios
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (31) : 3658 - 3664
  • [2] 'LDL-C' = LDL-C plus Lp(a)-C: implications of achieved ultra-low LDL-C levels in the proprotein convertase subtilisin/kexin type 9 era of potent LDL-C lowering
    Yeang, Calvin
    Witztum, Joseph L.
    Tsimikas, Sotirios
    CURRENT OPINION IN LIPIDOLOGY, 2015, 26 (03) : 169 - 178
  • [3] A modified Sampson LDL-C equation to improve concordance with the reference method at low levels of LDL-C
    Sampson, M.
    Meeusen, J. W.
    Donato, L. J.
    Jaffe, A. S.
    Remaley, A. T.
    CLINICAL CHEMISTRY, 2024, 70 : I88 - I88
  • [4] COMPARISON OF SIGMA DIRECT LDL-C AND THE CALCULATED LDL-C
    HOHNADEL, DC
    VANVESSEM, T
    ROWLAND, S
    DSOUZA, J
    CLINICAL CHEMISTRY, 1995, 41 (06) : S198 - S198
  • [5] Monogenic and polygenic causes of low and extremely low LDL-C levels in patients referred to specialty lipid clinics: Genetics of low LDL-C
    Jakubowski, Brandon
    Shao, Yanqiu
    McNeal, Catherine
    Xing, Chao
    Ahmad, Zahid
    JOURNAL OF CLINICAL LIPIDOLOGY, 2021, 15 (05) : 658 - 664
  • [6] Low-Density Lipoprotein Cholesterol (LDL-C): How Low?
    Whayne, Thomas F., Jr.
    CURRENT VASCULAR PHARMACOLOGY, 2017, 15 (04) : 374 - 379
  • [7] Comparing calculated LDL-C with direCtly measured LDL-C in healthy and in dyslipidemic children
    Garoufi, Anastasia
    Drakatos, Antonis
    Tsentidis, Charalampos
    Klinaki, Eleni
    Paraskakis, Irene
    Marmarinos, Antonios
    Gourgiotis, Dimitrios
    CLINICAL BIOCHEMISTRY, 2017, 50 (1-2) : 16 - 22
  • [8] LIPOPROTEIN(A) CHOLESTEROL CONTRIBUTION TO "LDL-C" LOWERS THE ABILITY OF A STATIN TO REDUCE "LDL-C"
    Schrock, C.
    ATHEROSCLEROSIS, 2022, 355 : E143 - E143
  • [9] LDL-C: lower is better for longer—even at low risk
    Peter E. Penson
    Matteo Pirro
    Maciej Banach
    BMC Medicine, 18
  • [10] Low LDL-C levels and cancer - Reassuring but still not definitive
    Ben-Yehuda, Ori
    DeMaria, Anthony N.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (14) : 1150 - 1151
12345